Bazaar Alan Lee 4

What Happened Alan Lee Bazaar, a director of Orthofix Medical Inc. (OFIX), received a grant of 14,965 deferred stock units on June 10, 2026. The reported acquisition price is $0.00 per unit (award), so the Form 4 lists no cash outlay. Each deferred stock unit represents a contingent right to one share of Orthofix common stock and the award vests in full on the first anniversary of the grant date, subject to continued service.

Key Details

• Transaction date: 2026-06-10; Transaction code: A (award/grant). Report filed 2026-06-12 (timely).
• Granted: 14,965 deferred stock units at $0.00 per unit (total reported value $0).
• Shares owned after transaction: 58,594 total beneficially owned (14,965 new DSUs + 42,929 previously reported DSUs + 700 shares bought under Orthofix’s Stock Purchase Plan).
• Footnote on vesting/settlement: DSUs vest in full on the first anniversary (subject to service). Vested DSUs will settle and convert into common stock within 45 days of the reporting person’s termination of service (per filing).
• Footnote on SPP: The 700 shares reflect purchases under Orthofix’s Stock Purchase Plan (10/31/2025 and 4/30/2026); SPP purchases are exempt from Section 16(b).

Context This was an equity award (deferred stock units), not an open-market purchase or sale; such awards are common as compensation or director pay and do not by themselves indicate a buy/sell signal. The units are subject to a one-year service-based vesting schedule and will only convert to actual shares per the settlement terms noted above. The Form 4 was filed within the standard 2‑business‑day window.